Solvent Diversity in Polymorph Screening-Reference-Cited by-同舟云学术

Solvent Diversity in Polymorph Screening

Published:2008-06 Issue:6 Volume:97 Page:2145-2159
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Allesø Morten,van den Berg Frans,Cornett Claus,Jørgensen Flemming Steen,Halling-Sørensen Bent,de Diego Heidi Lopez,Hovgaard Lars,Aaltonen Jaakko,Rantanen Jukka

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. Polymorphism;McCrone,1965

2. Crystal structures of drugs: Advances in determination, prediction and engineering;Datta;Nat Rev Drug Discov,2004

3. Crystalline solids;Vippagunta;Adv Drug Deliv Rev,2001

4. Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development;Chemburkar;Org Process Res Dev,2000

5. Automation of solid form screening procedures in the pharmaceutical industry—how to avoid the bottlenecks;Storey;Crystallogr Rev,2004

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydrates of N-(Anthracen-9-ylmethyl)-3-(1H-imidazolium-1-yl)propan-1-ammonium Zinc(II) or Cobalt(II) 2,6-pyridinedicarboxylate: Inter-conversions, assembling and utilities;Inorganic Chemistry Communications;2024-10

2. A Comprehensive Workflow towards More Equant‐Shaped Crystals of Active Pharmaceutical Ingredients;Chemical Engineering & Technology;2024-01-10

3. Hydrates of N-(Anthracen-9-ylmethyl)-3-(1H-imidazolium-1-yl)propan-1-ammonium Zinc(II) or Cobalt(II) 2,6-pyridinedicarboxylate: Inter-conversions, Assembling and Utilities;2024

4. A rapid solid form risk assessment workflow for ophthalmic drug candidates;Drug Development and Industrial Pharmacy;2023-06-03

5. Resolving Analytical Challenges in Pharmaceutical Process Monitoring Using Multivariate Analysis Methods: Applications in Process Understanding, Control, and Improvement;Spectroscopy;2023-03-01